Punch: Preliminary results from a phase II study of intra-arterial chemotherapy (IAC) combined with tislelizumab and bacillus Calmette-Guerin (BCG) in high-risk non-muscle-invasive bladder cancer (HR NMIBC).

被引：0
|
作者：
Wang, Zongren [1 ]
Zhan, Wenhao [1 ]
Huang, Bin [1 ]
Luo, Cheng [1 ]
Chen, Lingwu [1 ]
Chen, Junxing [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-138-226-9326; 613-135-2370-7650-2454; 613-4678-146-11576; 613-135-244-3829; 6; 5; 4; 3; 2; 158; 2424; 1714; 76; 62; 1; 38092-20390; 38092-29187;
D O I：
10.1200/JCO.2024.42.4_suppl.618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：618 / 618
页数：1
相关论文
共 50 条
  • [41] Treatment patterns with intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer (NMIBC): A real-world data analysis.
    Sun, Ran
    Linghu, Bolan
    Somer, Robert A.
    Hampras, Shalaka
    Bhanvadia, Sumeet Kaur
    Scherer, Emily
    Greshock, Joel
    Sweiti, Hussein
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Atezolizumab (atezo) with or without Bacille Calmette-Guerin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study.
    Hahn, Noah M.
    Steinberg, Gary D.
    Stratton, Kelly Lynn
    Kopp, Ryan P.
    Sankin, Alexander
    Skinner, Eila C.
    Pohar, Kamal S.
    Gartrell, Benjamin Adam
    Pham, Song
    Rishipathak, Deepali
    Mariathasan, Sanjeev
    Davarpanah, Nicole N.
    Carter, Corey
    Inman, Brant Allen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [43] Bacillus Calmette-Guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction: Phase III KEYNOTE-676 study.
    Kamat, Ashish M.
    Shore, Neal D.
    Hahn, Noah M.
    Alanee, Shaheen Riadh
    Nishiyama, Hiroyuki
    Shariat, Shahrokh F.
    Nam, Kijoeng
    Kapadia, Ekta
    Frenkl, Tara L.
    Steinberg, Gary D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Study of real-world treatment patterns and adherence to bacillus Calmette-Guerin (BCG) in the context of guideline recommendations for patients with high-risk non-muscle invasive bladder cancer (NMIBC).
    Gaylis, Franklin D.
    Emond, Bruno
    Manceur, Ameur M.
    Tardif-Samson, Anabelle
    Morrison, Laura
    Pilon, Dominic
    Lefebvre, Patrick
    Ellis, Lorie
    Balaji, Hiremagalur parthasarathy
    Ireland, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [45] Contemporary Cost-Effectiveness Analysis Comparing Sequential Bacillus Calmette-Guerin and Electromotive Mitomycin Versus Bacillus Calmette-Guerin Alone for Patients With High-Risk Non-Muscle-Invasive Bladder Cancer
    Bachir, Bassel G.
    Dragomir, Alice
    Aprikian, Armen G.
    Tanguay, Simon
    Fairey, Adrian
    Kulkarni, Girish S.
    Breau, Rodney H.
    Black, Peter C.
    Kassouf, Wassim
    CANCER, 2014, 120 (16) : 2424 - 2431
  • [46] Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guerin (BCG): results of an international individual patient data survey (IPDS)
    Witjes, J. Alfred
    Palou, Joan
    Soloway, Mark
    Lamm, Donald
    Kamat, Ashish M.
    Brausi, Maurizio
    Persad, Raj
    Buckley, Roger
    Colombel, Marc
    Boehle, Andreas
    BJU INTERNATIONAL, 2013, 112 (06) : 742 - 750
  • [47] The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
    Racioppi, Marco
    Di Gianfrancesco, Luca
    Ragonese, Mauro
    Palermo, Giuseppe
    Sacco, Emilio
    Bassi, PierFrancesco
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (05) : 507 - 512
  • [48] Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis
    Cheng, Chunliang
    Qiu, Dongxu
    Chen, Jinbo
    Zu, Xiongbing
    Liu, Jinhui
    Li, Huihuang
    Hu, Jiao
    Yi, Zhenglin
    He, Tongchen
    Chen, Zhi
    Cui, Yu
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] The Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
    Krajewski, Wojciech
    Zdrojowy, Romuald
    Dembowski, Janusz
    Poletajew, Slawomir
    Wrobel, Michal
    Luczak, Mateusz
    Tukiendorf, Andrzej
    Kolodziej, Anna
    UROLOGIA INTERNATIONALIS, 2019, 102 (01) : 60 - 68
  • [50] Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guerin for patients with high-risk non-muscle invasive bladder cancer
    Jamil, Marcus L.
    Deebajah, Mustafa
    Sood, Akshay
    Robinson, Kathy
    Rao, Krishna
    Sana, Sherjeel
    Alanee, Shaheen
    BMJ OPEN, 2019, 9 (07):
12345